COMPOSICION TROMBOLITICA

ESTA INVENCION HACE REFERENCIA A UNA TERAPIA DE COMBINACION TROBOLITICA MEDIANTE LA ADMINISTRACION DE UN AGENTE CAPAZ DE ACTIVAR PLASMINOGENO NATURAL, Y ANALOGO DE PLASMINOGENO NO NATURAL QUE ES DIVISIBLE POR LA TROMBINA NATURAL PARA GENERAR ACTIVIDAD DE PLASMINA. PCT No. PCT/GB95/01388 Sec. 371 Dat...

Full description

Saved in:
Bibliographic Details
Main Authors DAWSON, KEITH MARTYN, WOOD, LARS MICHAEL, COMER, MICHAEL BERISFORD
Format Patent
LanguageSpanish
Published 01.07.2004
Edition7
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:ESTA INVENCION HACE REFERENCIA A UNA TERAPIA DE COMBINACION TROBOLITICA MEDIANTE LA ADMINISTRACION DE UN AGENTE CAPAZ DE ACTIVAR PLASMINOGENO NATURAL, Y ANALOGO DE PLASMINOGENO NO NATURAL QUE ES DIVISIBLE POR LA TROMBINA NATURAL PARA GENERAR ACTIVIDAD DE PLASMINA. PCT No. PCT/GB95/01388 Sec. 371 Date Mar. 18, 1997 Sec. 102(e) Date Mar. 18, 1997 PCT Filed Jun. 14, 1995 PCT Pub. No. WO95/35117 PCT Pub. Date Dec. 28, 1995The invention disclosed relates to thrombolytic combination therapy by the administration of an agent capable of activating native plasminogen, and a non-native plasminogen analogue which is cleavable by native thrombin to generate plasmin activity.
Bibliography:Application Number: ES19950924413T